mTOR Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on mTOR Inhibitors

mTOR Inhibitors Adam Faletsky Shaiba Sandhu Herve Y. Sroussi Lauren M. Guggina The mammalian target of rapamycin (mTOR) is an important factor in cell growth and survival. mTOR is a…

read more

PI3-Kinase Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on PI3-Kinase Inhibitors

PI3-Kinase Inhibitors Shaiba Sandhu Ashleigh Eberly Puleo Nicole R. LeBoeuf The phosphoinositide 3-kinase (PI3K) pathway is important in cell survival, proliferation, and differentiation1 and is frequently altered in human cancers;…

read more

MEK Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on MEK Inhibitors

MEK Inhibitors Michael S. Chang Rebecca I. Hartman The mitogen-activated protein kinase (MAPK) pathway is highly implicated in aberrant signaling leading to carcinogenesis. Primary targets of this signaling cascade include…

read more

BRAF Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on BRAF Inhibitors

BRAF Inhibitors Jordan Talia Christine M. Cornejo Jesse Hirner BRAF is an oncogene encoding the BRAF protein, a component of the MAPK signaling pathway, that regulates cell proliferation, differentiation, survival,…

read more

Epidermal Growth Factor Receptor (EGFR) Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Epidermal Growth Factor Receptor (EGFR) Inhibitors

Epidermal Growth Factor Receptor (EGFR) Inhibitors Timothy M. Dang Daniela Kroshinsky The human epidermal growth factor receptor (HER) family of proteins is normally involved in cell growth and survival.1 HER1,…

read more

Bleomycin

Nov 1, 2025 by in ONCOLOGY Comments Off on Bleomycin

Bleomycin Jasmine Rana Bernice Y. Kwong A fermentation product of Streptococcus verticillus, bleomycin exerts a cytotoxic effect on replicating cells by inducing DNA double strand breaks. Bleomycin is administered systemically…

read more

Microtubule Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Microtubule Inhibitors

Microtubule Inhibitors Timothy M. Dang Daniela Kroshinsky Microtubule inhibitors are comprised of largely two classes of chemotherapy—taxanes and vinca alkaloids. Taxanes are cytotoxic drugs that promote the polymerization of tubulin…

read more

Anthracyclines

Nov 1, 2025 by in ONCOLOGY Comments Off on Anthracyclines

Anthracyclines Emma H. Weiss Caroline A. Nelson Jonathan S. Leventhal Anthracycline antibiotics are derived from Streptomyces species and are a commonly used cytotoxic treatment for both solid and hematologic malignancies…

read more

Antimetabolites

Nov 1, 2025 by in ONCOLOGY Comments Off on Antimetabolites

Antimetabolites Sheila Shaigany Paul I. Schneiderman Antimetabolites represent a broad class of chemotherapy agents that halt tumor growth by disrupting cellular division in the S phase of the cell cycle….

read more

Topoisomerase Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Topoisomerase Inhibitors

Topoisomerase Inhibitors Abdulhadi Jfri Christopher Iriarte Victor Huang Topoisomerases are enzymes involved in DNA structure, specifically in breaking and rejoining the phosphodiester backbone of double stranded DNA.1 Topoisomerase I inhibitors…

read more
Get Clinical Tree app for offline access